4.7 Article

Prevalence of acquired AmpC β-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes at a Spanish hospital from 1999 to 2007

Journal

CLINICAL MICROBIOLOGY AND INFECTION
Volume 16, Issue 5, Pages 473-476

Publisher

WILEY-BLACKWELL
DOI: 10.1111/j.1469-0691.2009.02864.x

Keywords

AmpC beta-lactamases; antimicrobial resistance mechanism; epidemiology of resistance

Funding

  1. Ministerio de Sanidad y Consumo
  2. Instituto de Salud Carlos III-FEDER
  3. Spanish Network for the Research in Infectious Diseases [REIPI C03/14, REIPI RD06/0008]

Ask authors/readers for more resources

P>In 2007, a significant increase in acquired ampC genes in Enterobacteriaceae from 0.06% in 1999 to 1.3% was observed. Proteus mirabilis showed the highest prevalence (0.95%) and CMY-2 was the most prevalent AmpC enzyme (66.7%). Other enzymes such as CMY-4, DHA-1, ACC-1, and three new enzymes called CMY-25, CMY-27 and CMY-40 were detected. Seven out of the 117 isolates (6%) also produced an extended-spectrum beta-lactamase. As acquired AmpC enzymes are likely to become a serious public health issue worldwide, close surveillance is necessary to curb their spread.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available